Page 102 - GTM-2-3

Global Translational Medicine Autoimmune diseases after vaccination

ADAEs associated with Kawasaki disease have been J Transl Int Med, 7: 137–142.
observed in relation to multiple vaccines (PNC, 6VAX- https://doi.org/10.2478/jtim-2019-0028
F, RV, MENB, and HIBV). These observations suggest
a potential link between immunization-stimulated 6. Sencer D, Millar JD, 2006, Reflections on the 1976 swine flu
antibodies and the activation of mast cells. It concludes vaccination program. Emerg Infect Dis J, 12: 29–33.
by proposing a further investigation into therapeutics https://doi.org/10.3201/eid1201.051007
targeting mast cell activation for Kawasaki disease patients. 7. Vellozzi C, Iqbal S, Broder K, 2014, Guillain-Barré syndrome,
influenza, and influenza vaccination: The epidemiologic
Acknowledgments evidence. Clin Infect Dis, 58: 1149–1155.
None. https://doi.org/10.1093/cid/ciu005

Funding 8. Ahmed SS, Schur PH, MacDonald NE, et al., 2014,
Narcolepsy, 2009 A(H1N1) pandemic influenza, and
None. pandemic influenza vaccinations: What is known and
unknown about the neurological disorder, the role for
Conflict of interest autoimmunity, and vaccine adjuvants. J Autoimmun,
The author declares that he/she has no competing interests. 50: 1–11.
https://doi.org/10.1016/j.jaut.2014.01.033
Author contributions
9. David P, Shoenfeld Y, 2020, ITP following vaccination. Int J
This is a single-authored article. Infect Dis, 99: 243–244.
Ethics approval and consent to participate https://doi.org/10.1016/j.ijid.2020.07.085
10. Black C, Kaye JA, Jick H, 2003, MMR vaccine and idiopathic
Not applicable. thrombocytopaenic purpura. Br J Clin Pharmacol,
55: 107–111.
Consent for publication
https://doi.org/10.1046/j.1365-2125.2003.01790.x
Not applicable.
11. Jin CQ, Dong HX, Sun ZX, et al., 2013, Acute immune
Availability of data thrombocytopenic purpura as adverse reaction to oral polio
vaccine (OPV). Hum Vaccin Immunother, 9: 1739–1740.
The vaers_slice2.rb reports are available here: Ricke D,
2023, “ADAE Post Vaccination”, Harvard Dataverse, V1, https://doi.org/10.4161/hv.24847
https://doi.org/10.7910/DVN/EROCQQ. 12. Chen Y, Xu Z, Wang P, et al., 2022, New-onset autoimmune
phenomena post-COVID-19 vaccination. Immunology,
References 165: 386–401.

1. VAERS, 2023, Vaccine Adverse Event Reporting System. U.S. https://doi.org/10.1111/imm.13443
Department of Health and Human Services. Available from: 13. May Lee M, Bertolani M, Pierobon E, et al., 2022, Alopecia
https://vaers.hhs.gov/data/datasets.html [Last accessed on areata following COVID-19 vaccination: Vaccine-induced
2023 Aug 08]. autoimmunity? Int J Dermatol, 61: 634–635.
2. Vadalà M, Poddighe D, Laurino C, et al., 2017, Vaccination https://doi.org/10.1111/ijd.16113
and autoimmune diseases: Is prevention of adverse health
effects on the horizon? EPMA J, 8: 295–311. 14. Rossini A, Cassibba S, Perticone F, et al., 2023, Increased
prevalence of autoimmune thyroid disease after COVID-
https://doi.org/10.1007/s13167-017-0101-y 19: A single-center, prospective study. Front Endocrinol
3. Guimarães LE, Baker B, Perricone C, et al., 2015, Vaccines, (Lausanne), 14: 1126683.
adjuvants and autoimmunity. Pharmacol Res, 100: 190–209.
https://doi.org/10.3389/fendo.2023.1126683
https://doi.org/10.1016/j.phrs.2015.08.003
15. Guo M, Liu X, Chen X, et al., 2023, Insights into new-
4. Seida I, Seida R, Elsalti A, et al., 2023, Vaccines and onset autoimmune diseases after COVID-19 vaccination.
autoimmunity-from side effects to ASIA syndrome. Autoimmun Rev, 22: 103340.
Medicina (Kaunas), 59: 364. https://doi.org/10.1016/j.autrev.2023.103340
https://doi.org/10.3390/medicina59020364
16. Ishay Y, Kenig A, Tsemach-Toren T, et al., 2021, Autoimmune
5. Babazadeh A, Afshar ZM, Javanian M, et al., 2019, Influenza phenomena following SARS-CoV-2 vaccination. Int
vaccination and Guillain-Barré syndrome: Reality or fear. Immunopharmacol, 99: 107970.

Volume 2 Issue 3 (2023) 9 https://doi.org/10.36922/gtm.1455